Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-14-012684
Filing Date
2014-07-11
Accepted
2014-07-11 16:45:51
Documents
1
Period of Report
2014-07-10

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A imnp20140710_pre14a.htm PRE 14A 648680
  Complete submission text file 0001437749-14-012684.txt   649790
Mailing Address 708 THIRD AVENUE SUITE 210 NEW YORK NY 10017
Business Address 708 THIRD AVENUE SUITE 210 NEW YORK NY 10017 914-606-3500
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-51290 | Film No.: 14971957
SIC: 2834 Pharmaceutical Preparations